Skip to main content
Leiden University
Scholarly Publications
Home
Submit
About
Select Collection
All collections
Academic speeches
Dissertations
Faculty of Archaeology
Faculty of Governance and Global Affairs
Faculty of Humanities
Faculty of Science
Faculty of Social and Behavioural Sciences
Leiden Journals, Conference Proceedings and Books
Leiden Law School
Leiden University Press
Medicine / Leiden University Medical Centre (LUMC)
Research output UL
Search box
Your Search
Enabled Filters
(-)
= Lam, S.W.
Sort Options
Date (year)
Author / Creator
Title
Refine Results
Resource Type
Article / Letter to editor
(24)
+
-
Availability
Open access
(12)
+
-
Metadata Only
(13)
+
-
Creation Date
2021
(5)
+
-
2022
(4)
+
-
2015
(3)
+
-
2023
(3)
+
-
2016
(2)
+
-
2018
(2)
+
-
2019
(2)
+
-
2020
(2)
+
-
Show more
Faculty
Leiden University Medical Center (LUMC)
(21)
+
-
Collection
Medicine / Leiden University Medical Centre (LUMC)
(21)
+
-
Scholarly Publications
(4)
+
-
Topic
FOS
(4)
+
-
Capecitabine
(3)
+
-
Paclitaxel
(3)
+
-
immunohistochemistry
(3)
+
-
Bevacizumab
(2)
+
-
Efficacy
(2)
+
-
Genetic polymorphisms
(2)
+
-
Immunohistochemistry
(2)
+
-
Molecular pathology
(2)
+
-
Osteoblastoma
(2)
+
-
Osteoid osteoma
(2)
+
-
Targeted therapy
(2)
+
-
Toxicity
(2)
+
-
bone and soft tissue tumors
(2)
+
-
bone tumor
(2)
+
-
Show more
Author
Lam, S.W.
(25)
+
-
Bovee, J.V.M.G.
(13)
+
-
E. boven
(9)
+
-
Cleton-Jansen, A.M.
(7)
+
-
Szuhai, K.
(7)
+
-
Honkoop, A.H.
(6)
+
-
Cleven, A.H.G.
(5)
+
-
Guchelaar, H.J.
(5)
+
-
Jager, A.
(5)
+
-
Bosch, J. van den
(4)
+
-
Groot, S.M. de
(4)
+
-
Kroep, J.R.
(4)
+
-
Linn, S.C.
(4)
+
-
Wezel, T. van
(4)
+
-
Baumhoer, D.
(3)
+
-
Bos, M.M.E.M.
(3)
+
-
Frederiks, C.N.
(3)
+
-
Kroon, H.M.
(3)
+
-
M. los
(3)
+
-
Morreau, H.
(3)
+
-
Portielje, J.E.A.
(3)
+
-
Smorenburg, C.H.
(3)
+
-
Straaten, T. van der
(3)
+
-
Tinteren, H. van
(3)
+
-
Velden, A.M.T. van der
(3)
+
-
Aghmuni, G.A.
(2)
+
-
Berends, J.
(2)
+
-
Boer, M.O. den
(2)
+
-
Boot, A.
(2)
+
-
Braun, H.J.
(2)
+
-
Braun, J.J.
(2)
+
-
Briaire-de Bruijn, I.H.
(2)
+
-
Cohen, D.
(2)
+
-
Douma, J.
(2)
+
-
Egmond, D. van
(2)
+
-
Hondelink, L.M.
(2)
+
-
Jeurissen, F.
(2)
+
-
Khalifa, M.N.
(2)
+
-
Nota, N.M.
(2)
+
-
Ouahoud, S.
(2)
+
-
Riel, J.M.G.H. van
(2)
+
-
Savci-Heijink, D.C.
(2)
+
-
Schrader, A.M.R.
(2)
+
-
Silva, T.M.
(2)
+
-
Solleveld-Westerink, N.
(2)
+
-
Tanis, B.
(2)
+
-
Terwogt, J.M.M.
(2)
+
-
Show more
Language
en
(25)
+
-
Search results
(1 - 24 of 25)
Pages
1
2
›
››
show grid
show list
save search
Imaging in interventional oncology, the better you see, the better you treat
Histological response to radiotherapy is an early event in myxoid liposarcoma
Plasma ESR1 mutations and outcome to first-line paclitaxel and bevacizumab in patients with advanced ER-positive/HER2-negative breast cancer
GRM1 immunohistochemistry distinguishes chondromyxoid fibroma from its histologic mimics
The sensitivity of pan-TRK immunohistochemistry in solid tumours: A meta-analysis
New molecular entities of soft tissue and bone tumors
The sensitivity of pan-TRK immunohistochemistry in solid tumours
Expanding the spectrum of EWSR1-NFATC2-rearranged benign tumors a common genomic abnormality in vascular malformation/hemangioma and simple bone cyst
Molecular pathology in bone and soft tissue tumors
NTRK fusions are extremely rare in bone tumours
Mismatch repair deficiency is rare in bone and soft tissue tumors
FOS rearrangement and expression in cementoblastoma
Loss of NF2 defines a genetic subgroup of non-FOS-rearranged osteoblastoma
Utility of FOS as diagnostic marker for osteoid osteoma and osteoblastoma
What's new in bone forming tumours of the skeleton?
Molecular Pathology of Bone Tumors
Molecular Analysis of Gene Fusions in Bone and Soft Tissue Tumors by Anchored Multiplex PCR-Based Targeted Next-Generation Sequencing
Single-nucleotide polymorphisms in the genes of CES2, CDA and enzymatic activity of CDA for prediction of the efficacy of capecitabine-containing chemotherapy in patients with metastatic breast cancer
The role of pharmacogenetics in capecitabine efficacy and toxicity
Genotypes of CYP2C8 and FGD4 and their association with peripheral neuropathy or early dose reduction in paclitaxel-treated breast cancer patients
Genetic polymorphisms and paclitaxel- or docetaxel-induced toxicities: A systematic review
Genetic polymorphisms (SNPs) as predictive markers for paclitaxel-induced peripheral neuropathy (PNP) and capecitabine-induced hand-foot syndrome (HFS) in HER-2 negative metastatic breast cancer patients
Plasma biomarker analysis in patients with HER2-negative locally recurrent or metastatic breast cancer (LR/MBC) treated with first-line bevacizumab (A) and paclitaxel (T) without or with capecitabine (X)
Paclitaxel and bevacizumab with or without capecitabine as first-line treatment for HER2-negative locally recurrent or metastatic breast cancer: A multicentre, open-label, randomised phase 2 trial
Pages
1
2
›
››